Details for Patent: 9,737,547
✉ Email this page to a colleague
Which drugs does patent 9,737,547 protect, and when does it expire?
Patent 9,737,547 protects BYFAVO and is included in one NDA.
This patent has twenty-one patent family members in sixteen countries.
Drugs Protected by US Patent 9,737,547
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acacia | BYFAVO | remimazolam besylate | POWDER;INTRAVENOUS | 212295-001 | Oct 6, 2020 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | USE OF REMIMAZOLAM FOR INDUCTION AND MAINTENANCE OF PROCEDURAL SEDATION IN ADULTS UNDERGOING PROCEDURES LASTING 30 MINUTES OR LESS | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,737,547
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 10014366 | Nov 8, 2010 | |
| 10014784 | Nov 19, 2010 | |
| 10014819 | Nov 22, 2010 | |
| PCT Information | |||
| PCT Filed | November 07, 2011 | PCT Application Number: | PCT/EP2011/005581 |
| PCT Publication Date: | May 18, 2012 | PCT Publication Number: | WO2012/062439 |
International Family Members for US Patent 9,737,547
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2011328497 | ⤷ Subscribe | |||
| China | 103347519 | ⤷ Subscribe | |||
| Denmark | 2637662 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
